vorinostat has been researched along with Degenerative Diseases, Central Nervous System in 7 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Song, Y | 1 |
| Lim, J | 1 |
| Seo, YH | 1 |
| Athaide Rocha, KM | 1 |
| Machado, FR | 1 |
| Poetini, M | 1 |
| Giacomeli, R | 1 |
| Boeira, SP | 1 |
| Jesse, CR | 1 |
| Gomes de Gomes, M | 1 |
| Alqinyah, M | 1 |
| Hooks, SB | 1 |
| Cao, F | 1 |
| Zwinderman, MRH | 1 |
| Dekker, FJ | 1 |
| Takamatsu, G | 1 |
| Katagiri, C | 1 |
| Tomoyuki, T | 1 |
| Shimizu-Okabe, C | 1 |
| Nakamura, W | 1 |
| Nakamura-Higa, M | 1 |
| Hayakawa, T | 1 |
| Wakabayashi, S | 1 |
| Kondo, T | 1 |
| Takayama, C | 1 |
| Matsushita, M | 1 |
| Hori, S | 1 |
| Kakizuka, A | 1 |
| Rouaux, C | 1 |
| Loeffler, JP | 1 |
| Boutillier, AL | 1 |
4 reviews available for vorinostat and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Regulating the regulators: Epigenetic, transcriptional, and post-translational regulation of RGS proteins.
Topics: Animals; Azacitidine; Benzodiazepines; Cardiovascular Diseases; Drugs, Investigational; Epigenesis, | 2018 |
The Process and Strategy for Developing Selective Histone Deacetylase 3 Inhibitors.
Topics: Antineoplastic Agents; Chemistry Techniques, Synthetic; Depsipeptides; Drug Design; Epigenesis, Gene | 2018 |
[Therapeutic targets in polyglutamine diseases].
Topics: Adenosine Triphosphatases; Animals; Antineoplastic Agents; Benzoquinones; Cell Cycle Proteins; Congo | 2004 |
Targeting CREB-binding protein (CBP) loss of function as a therapeutic strategy in neurological disorders.
Topics: Animals; Apoptosis; CREB-Binding Protein; Drug Delivery Systems; Enzyme Inhibitors; Histone Deacetyl | 2004 |
3 other studies available for vorinostat and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
A novel class of anthraquinone-based HDAC6 inhibitors.
Topics: Acetylation; Anthraquinones; Cell Line, Tumor; Enzyme Assays; Histone Deacetylase 6; Histone Deacety | 2019 |
Assessment of suberoylanilide hydroxamic acid on a Alzheimer's disease model induced by β-amyloid
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain-Derived Neurotrophic Factor; Epigenesis, Ge | 2023 |
Tescalcin is a potential target of class I histone deacetylase inhibitors in neurons.
Topics: Animals; Calcineurin; Calcium; Calcium-Binding Proteins; Cluster Analysis; Epigenesis, Genetic; Gene | 2017 |